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Gregory L. Moneta, MD, Section EditorAssociation Between Serum Lipoproteins and Abdominal Aortic
Aneurysm
Golledge J, van Bochxmeer F, Jamrozik K, et al. Am J Cardiol 2010;105:
1480-4.
Conclusion: High-density lipoprotein is the most important lipid in
predicting the risk of development of an abdominal aortic aneurysm (AAA).
Summary: The relationship between dyslipidemia and development of
AAA is unclear. Some studies have reported an association between low-
density lipoprotein (LDL) or high-density lipoprotein (HDL) and AAA;
others have found no association. Previous studies have not used consistent
definitions of dyslipidemia, have not stratified the current use of lipid
modifying medications, and often have not adjusted for other determinants
of AAA. The result has been confusion regarding the role of dyslipidemia in
the development of AAA.
The current study was designed to examine the association of serum
concentration of lipids and AAA in a population screening study. Data were
adjusted for known clinical determinants of AAA and use of lipid-modifying
medications. The study analyzed 3327men aged 65 to 83 years. Analysis was
adjusted for established risk factors of AAA and the presence of prescriptions
of lipid-modifying agents. At the time of fasting lipid measurement, 1043
men (31%) were receiving lipid-modifying therapy; statins in 98% of the
cases. Serum HDL concentrations were lower in patients with AAA. HDL
concentration was independently associated with a decreased risk of an AAA
in men not receiving lipid-modifying therapy (odds ratio, 0.72; 95% confi-
dence interval, 0.56-0.93 per 0.4-mM increase) as well as in the total cohort
(odds ratio, 0.76; 95% confidence interval, 0.63-0.91 per 0.4-mM increase,
adjusted for lipid-modifying therapy). Levels of triglycerides and LDL were
not associated with the presence of AAA.
Comment: The authors have demonstrated a consistent association
between a low serum HDL concentration and the presence of AAA in a
population prone to aortic dilatation. The fact that the association was
present in subgroups not receiving lipid-modifying medications and in men
after adjusting for other risk factors, including lipid-modifying medications,
is evidence modification of HDL levels may be a therapeutic target in the
prevention of AAA.
Atheroembolic Disease—A Frequently Missed Diagnosis: Results of a
12-Year Matched-Pair Autopsy Study
Fries C, Roos M, Gaspert A, et al. Medicine 2010;89:126-32.
Conclusion: Vascular interventions are the most important risk factor
for atheroembolic disease.
Summary: Vascular embolism was first described by Flory in 1944
(Flory CM. Am J Pathol 1944;21:549-58). In cholesterol embolization,
cholesterol crystals are released into the circulation through erosion of an
atherosclerotic plaque. Plaque contents are flushed into the distal arterial
beds and lodged into vessels 150 to 200 m in diameter. The microemboli
trigger an inflammatory reaction that eventually occludes the artery (Keen
RR, et al. J Vasc Surg 1995;21:773-81). Diagnosis of atheroembolic disease
is hampered because atheroembolic disease is associated with multiple
symptoms and has only nonspecific laboratory findings. To better character-
ize this disorder, the authors sought to determine the relative frequency of
autopsy-proven atheroembolic disease during a 12-year period. They sought
to identify risk and precipitating factors and to identify factors that facilitate
diagnosis of atheroembolic disease by identifying laboratory and clinical
features potentially suggesting the disorder.
The authors screened 2066 autopsy reports from 1995 to 2006 for
evidence of atheroembolic disease. For each case of atheroembolic disease, a
control patient without atheroembolic disease was matched for autopsy year,
sex, and age. Records were analyzed for therapeutic and diagnostic interven-
tions in the last 6 months before death as well as laboratory and clinical
parameters during the last hospitalization before death.
They identified 51 patients with atheroembolic disease, and only 6
(12%) had been diagnosed clinically. The most frequently affected organs
were the lower gastrointestinal tract (22%), the spleen (37%), and the kidney
(71%). The frequency of clinically suspected and biopsy-proven atheroem-
bolic disease remained constant over time. Clinical signs increased in patients
with atheroembolic disease were livedo reticularis and blue toes compared
with patients without atheroembolic disease (33% vs 14 %; P  .04). There
was a trend for higher incidence of proteinuria and eosinophilia in the
atheroembolic disease patients. A vascular intervention 6 months before
death was highly associated with atheroembolic disease (55% vs 29%; P 
.01). After multivariable analysis, only a previous vascular intervention was
identified as a significant risk factor for atheroembolic disease.Comment: Atheroembolic disease has been associated with blue toe,
livedo reticularis, renal failure, pancreatitis, muscle pain, gastrointestinalbleeding, hypertension, peptic ulcer, inflammatory bowel disease, prostati-
tis, and hemorrhagic cystitis (Mollenaar W, et al. Am J Gastroenterol
1989;84:1421-2; and Mollenaar W, et al. Arch Intern Med 1996;156:653-
7). The current study confirms the widespread distribution of affected
organs and that atheroembolic disease is missed premorbidly in80% of the
cases. Given the plethora of potential clinical manifestations of atheroem-
bolic disease and that vascular interventions are the major risk factor for
atheroembolic disease, it is likely the complication rate of vascular interven-
tions is higher than suspected based on clinical criteria alone.
Bleeding Complications With Dual Antiplatelet Therapy Among
Patients With Stable Vascular Disease or Risk Factors for Vascular
Disease: Results From the Clopidogrel for High Atherothrombotic
Risk and Ischemic Stabilization, Management and Avoidance
(CHARISMA) Trial
Berger PB, Bhatt DL, Fuster V, et al. Circulation 2010;121:2575-83.
Conclusion: There is an increased risk of bleeding with long-term dual
antiplatelet therapy. The increased risk is greatest in the first year. Moderate
bleeding is associated with mortality.
Summary: It is known that dual antiplatelet therapy using clopidogrel
and aspirin is effective in reducing thrombotic events in patients with acute
coronary syndromes and those undergoing placement of bare and drug-
eluting coronary stents. In the original CHARISMA study, on a background
of aspirin therapy, clopidogrel was compared with placebo for amedian of 28
months for its ability to reduce thrombotic events. On this background of
aspirin therapy, clopidogrel did not reduce thrombotic events in the overall
study population (Bhatt DL, et al. N Engl J Med 2006;354:1706-17).
However, in patients with stable vascular disease, clopidogrel added to
aspirin led to a 12% relative decrease in cardiovascular death, myocardial
infarction, or stroke vs those who were treated for risk factors only, where
there was a 20% increase in these events (Bhatt DL, et al. J Am Coll Cardiol
2007;49:1982-88). Because the source of this increased risk in patients with
risk factors only may be bleeding, the authors sought to determine if
bleeding risk was sufficiently high to argue against dual antiplatelet therapy
even in patients with stable vascular disease who appear to benefit from dual
antiplatelet therapy.
The authors analyzed 15,603 patients enrolled in CHARISMA. This
was a double-blind, placebo-controlled, randomized trial comparing clopi-
dogrel (75 mg/d) vs placebo on a background of aspirin therapy (75 to 162
mg/d). Patients in CHARISMA were classified as having stable vascular
disease or multiple risk factors for vascular disease without established
disease. Median follow-up was 28 months. On this background of aspirin
therapy, severe bleeding occurred in 1.7% of the clopidogrel group vs 1.3%
of those treated with aspirin and placebo (P .087), and moderate bleeding
occurred in 2.1% vs 1.3%, respectively (P  .001). The primary risk of
bleeding was during the first year. Patients without severe or moderate
bleeding after 1 year were no more likely than placebo-treated patients to
have subsequent bleeding. Bleeding frequency was similar in patients with
risk factors only and in those with established vascular disease. The relation-
ship between moderate bleeding and all-cause mortality was strong (hazard
ratio [HR], 2.55; 95% confidence interval [CI], 1.71-3.80; P  .0001).
Strong relationships were also between moderate bleeding and myocardial
infarction (HR, 2.92; 95% CI, 1.71-3.8; P  .0001) and stroke (HR, 4.20;
95% CI, 3.05-5.77; P  .0001).
Comment: For the vascular surgeon who frequently treats his or her
patient with dual antiplatelet therapy, the bottom line is that such therapy
will be associated with a risk of moderate or severe bleeding of approximately
4%, and that this risk is greatest in the first year of therapy. In addition,
further analysis of the CHARISMA trial has indicated that in dual antiplate-
let therapy, lower-dose aspirin administered with clopidogrel has a lower risk
of bleeding than higher doses of aspirin (Steinhubl SR et al, Ann InternMed
2009;150:379-86). Overall, dual antiplatelet therapy administered to pa-
tients with established vascular disease lowers the risk of future cardiovascu-
lar events with a small but measurable increased risk of bleeding that, if it
occurs, will adversely affect mortality.
Blunt Traumatic Thoracic Aortic Injuries: Early or Delayed Repair—
Results of an American Association for the Surgery of Trauma Prospec-
tive Study
Demetriades D, Velmahos GC, Scalea TM, et al. J Trauma 2009;66:967-73.
Conclusion: Delayed repair of stable blunt thoracic aortic injury
provides improved survival over emergent repair, irrespective of the presence
of major additional associated injuries.
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October 20101112 AbstractsSummary: A number of individual case series have suggested blunt
traumatic thoracic aortic injury can be effectively managed with delayed
repair. The stimulus for delayed repair undoubtedly resulted from dissatis-
faction with the results of emergent operation, the greater availability of
endografts, and more widespread use of -blockers in the management of
thoracic aortic trauma. This study reports data from the American Associa-
tion for the Surgery of Trauma multicenter registry of 18 participating
trauma centers. It was observational and prospective, and data were acquired
from June 2005 through August 2007. Patients managed without aortic
repair or who were in extremis at presentation were excluded. Data collected
included clinical presentation, demographics, injury severity score, type of
aortic injury, type of aortic repair, and time from injury to aortic repair.
Patients were divided into groups according to early repair (24 hours) and
delayed repair (24 hours). Outcomes were compared with multivariate
analysis after adjustments for presence of hypertension, major associated
injuries, and type of aortic repair, as well as Glasgow Coma Scale. Patients
were also compared with delayed or early repair with respect to whether
there were underlying major associated injuries.
The study included 178 patients with thoracic aortic injuries, of whom
109 (61.2%) underwent early repair and 69 (38.8%) underwent delayed
repair. Demographics were similar in the two groups. Mortality was higher
in the early repair group (adjusted odds ratio, 7.8; 95% confidence interval
[CI], 1.69-35.70, P  .008). Complication rates were similar in the two
groups, but delayed repair was associated with longer lengths of stay in the
intensive care unit and in the hospital. Patients treated with early repair had
a trend toward a higher mortality rate (adjusted odds ratio, 9.1; 95% CI,
0.9-93.8, P .064). Early repair patients, however, had lower complication
rates (P  .04) and shorter intensive care unit stays (P  .02) than delayed
repair patients. There was a strong trend toward higher mortality in patients
with major associated injuries treated with early repair (odds ratio, 9.4; 95%
CI, 0.93-95.2; P  .058) without a difference in complication rates (P 
.239).
Comment: Delayed repair of blunt thoracic aortic injuries appears to
be safe but perhaps is associated with longer hospital lengths of stay and
higher direct costs than earlier repair. Overall, previous studies and the
current study suggest there is a survival advantage of delayed repair. Patients
with major associated injuries seem to benefit most with delayed repair, with
demonstrated improved survival and no increased systemic complications at
the expense of a longer length of stay than early repair. The data support
delayed repair in all patients with blunt thoracic aortic injuries irrespective of
risk factors. Patients with major associated injuries are most likely to benefit
from delayed repair.
Blunt Vertebral Artery Injuries in the Era of Computed Tomographic
Angiographic Screening: Incidence and Outcomes From 8292 Patients
Berne JD, Norwood SH. J Trauma 2009;67:1333-8.
Conclusion: An aggressive screening and individualized treatment
program for blunt vertebral artery injury can identify these injuries and
results in potentially a low rate of preventable strokes and deaths.
Summary:When patients are screened aggressively for blunt vertebral
artery injury (BVI) the incidence following appears to be 0.49% to 0.71%
(Miller PR, et al. Ann Surg 2002;236:386-95; and Berne JD, et al. J Trauma
2006;60:1204-10). This rate of identification of BVI appears to be higher
than in the prescreening era, where approximately 0.1% of patients with
blunt injuries were identified with BVI (Thibodeaux LC, et al. Br J Surg
1997;84:94). Stroke rates associate with BVI have been reported at 24%,
with BVImortality rates of 8% (BifflWL, et al. Ann Surg 2000;231:672-81).
The authors sought to determine whether screening and treatment for BVI
resulted in improved outcomes.
There were 8292 trauma patients admitted to the authors’ institution
between June 23, 2000, and December 31 2007. Of these, 47 had BVI (3
bilateral), and 37 patients were treated with pharmacologic therapy, heparin,
warfarin, or clopidogrel and aspirin. Treatment was with angiographic
coiling in eight patients (18%) and endovascular stents in two (5%). Four had
signs of cerebral ischemia, one of whom recovered completely and three
died. The mortality rate in the patients with BVI was 16%, and the BVI-
related mortality rate was 7%. Two patients with BVI-related mortality had
bilateral vertebral artery occlusion or transection. A posterior circulation
infarct developed in one patient after a unilateral vertebral dissection when it
was felt pharmacologic therapy was contraindicated secondary to intracranial
hemorrhage. Before the screening protocol in the authors’ institution,
BVI-related mortality was 0.75 cases/year, and during the study period it
was 0.57 cases/year.
Comment: The criteria for screening in the study included basilar skull
fractures, cervical spine injuries, severe facial fractures, and cervical hemato-
mas or cervical abrasions, as well as a Glasgow coma score 8 and lateraliz-
ing neurologic signs and mechanism of hanging for the injury. All patients
had sustained a high-speed deceleration incident or blunt cervical trauma,
and 86.4% of the BVI patients were identified by screening criteria alone.
Patients overall did well, with only one possibly preventable death from BVI.
What this study tells us is that patients with BVI identified through screeningand treated with a variety of modalities will have low neurologic morbidity
and mortality.
Changes in Red Blood Cell Transfusion Practice During the Turn of
the Millennium: A Retrospective Analysis of Adult Patients Undergo-
ing Elective Open Abdominal Aortic Aneurysm Repair Using theMayo
Database
Long TR, Curry TB, Stemmann JL, et al. Ann Vasc Surg 2010;24:447-54.
Conclusion:Change in transfusion practice, including the use of more
autotransfusions and tolerance of lower perioperative hemoglobin levels,
have not resulted in significant differences in perioperative morbidity or
mortality in patients undergoing open abdominal aortic aneurysm (AAA)
repair.
Summary: The average cost of the transfusion of a red blood cell
(RBC) unit is $153.68, and 14million units of RBCs are transfused annually
in the United States (Sullivan NT, et al. Transfusion 2007;47:385-94).
Currently, there is also enthusiasm for reducing the number of transfused
units because of reported increased morbidity and mortality with increased
transfusions and reported increased infectious complications with increased
transfusions. The authors sought to determine whether changes in transfu-
sion practice during a two-decade study had any impact on perioperative
morbidity and mortality in patients undergoing open elective AAA repair.
The authors stratified patients undergoing open elective AAA repair into one
of two transfusion-related groups. Early practice was defined as that between
1980 and 1982, and late practice was defined as between 2003 and 2006.
Hemoglobin concentration and RBC transfusion were analyzed as contin-
uous variables and compared between groups. Perioperative complications
were compared, and data were age adjusted and analyses corrected for
multiple comparisons.
Patients in the late practice group compared with those in the early
practice group had lower intraoperative (mean, 10  1.4 vs 11.5  1.5
g/dL), postoperative (mean, 11.9 1.4 vs 13.4 1.5 g/dL), and discharge
hemoglobin levels (mean, 10.8  1.2 vs. 12.5  1.5 g/dL; P  .0001 for
each variable). Fewer patients in the late practice group received intraoper-
ative allogenic transfusions (46% vs 99%, P .0001). There were also fewer
total allogenic units transfused in the late practice group (mean, 1.7 vs 4.3,
P  .0001). No patients in the early practice group had intraoperative
autotransfusions, whereas intraoperative autotransfusions were used in 97%
of the late practice patients (P  .0001). The incidence of perioperative
morbidity and mortality was 40% (n  119) in the late practice group and
35% (n  106) in the early practice group (P  .27).
Comment: RBC transfusion is associated with worse outcomes in
cardiac surgery patients and in patients experiencing acute coronary syn-
drome (Murphy GJ, et al. Circulation 2007;116:2544-52; and Rao SV.
JAMA 2004;292:1555-62). However, a randomized trial in critically ill
patients comparing liberal vs conservative RBC transfusion found no differ-
ence in survival with the two treatment strategies (Hebert PC, et al. N Engl
J Med 1999;340:409-47). The current study also found no difference in
major morbidity or mortality in patients undergoing AAA repair with respect
to a changing transfusion policy using more conservative thresholds for
transfusion. However, the patients did no worse, and given the expense
occurred with each unit transfused, a more conservative policy for patients
undergoing open AAA repair is at least indicated financially if not medically.
Damage Control Techniques for Common and External Iliac Artery
Injuries: Have Temporary Intravascular Shunts Replaced the Need for
Ligation?
Ball CG, Feliciano DV. J Trauma 2010;68:1117-20.
Conclusion: Temporary intravascular shunts (TIVSs) have replaced
ligation as primary damage control for injuries to the common and external
iliac artery. TIVs substantially eliminate the need for amputation in patients
with these injuries and provide improved likelihood of survival.
Summary: Iliac artery trauma is highly lethal, with mortality rates
ranging from 24% to 60% (Dente CJ, Feliciano DV. In: Feliciano DV,
Mattox KL, Moore EE, editors. Trauma. 6th ed. New York: McGraw-Hill
Medical; 2008. p. 737-57). Traditional damage control for iliac artery
injuries has been ligation and was associated with a 50% amputation rate and
up to a 90% mortality rate. The goal of this study was to identify the
consequences of using ligation vs TIVS for common or external iliac artery
injuries in damage control scenarios. From 1995 to 2008, patients with iliac
artery injuries were identified at a level 1 trauma center and were analyzed for
demographics and outcomes. There were 88 patients with iliac artery
injuries, comprising 71 external and 17 common iliac artery injuries; of
these, 72% were penetrating, and the median injury severity score (ISS) was
25. The mean hospital stay was 28 days. Nonsurvivors (73%) died of
refectory shock within the first 24 hours. Ligation was used in 1 common
(6%) and in 14 external (20%) iliac arteries, and TVISs were used in 2
common (12%) and in 5 external (7%) iliac arteries. Ligation was practiced
primarily between 1995 and 2005 and TIVs between 2005 and 2008.
Patients undergoing ligation or TIVS had similar demographics and injuries.
